Background: Patients undergoing emergency laparotomy present with a profound inflammatory response, which could be an independent pathophysiological component in prolonged recovery. The aim of this study was to investigate the effects of a single preoperative high dose of intravenous dexamethasone on the inflammatory response and recovery after emergency laparotomy.

Methods: In this double-blinded placebo-controlled trial, patients were prospectively stratified according to surgical pathology (intestinal obstruction and perforated viscus) and randomized to preoperative 1 mg/kg dexamethasone or placebo at a ratio of 1 : 1. The primary outcome was C-reactive protein on postoperative day 1. Secondary outcomes were postoperative recovery, morbidity, and mortality.

Results: A total of 120 patients were included in the trial. On postoperative day 1, the C-reactive protein response was significantly lower in the dexamethasone group (a median of 170 versus 220 mg/l for dexamethasone and for placebo respectively; P = 0.015; mean difference = 49 (95% c.i. 13 to 85) mg/l) and when stratified according to intestinal obstruction (a median of 60 versus 160 mg/l for dexamethasone and for placebo respectively; P = 0.002) and perforated viscus (a median of 230 versus 285 mg/l for dexamethasone and for placebo respectively; P = 0.035). Dexamethasone administration was associated with improved recovery (better haemodynamics, better pulmonary function, less fatigue, and earlier mobilization). Furthermore, the dexamethasone group had a lower 90-day mortality rate (7% versus 23% for dexamethasone and for placebo respectively; relative risk 0.33 (95% c.i. 0.11 to 0.93); P = 0.023) and a decreased incidence of postoperative major complications (27% versus 45% for dexamethasone and for placebo respectively; relative risk 0.62 (95% c.i. 0.37 to 1.00); P = 0.032).

Conclusion: A single preoperative high dose of intravenous dexamethasone significantly reduces the inflammatory response after emergency laparotomy and is associated with enhanced recovery and improved outcome.

Registration Number: NCT04791566 (http://www.clinicaltrials.gov).

Download full-text PDF

Source
http://dx.doi.org/10.1093/bjs/znae130DOI Listing

Publication Analysis

Top Keywords

dexamethasone placebo
24
preoperative high
12
high dose
12
dexamethasone
12
emergency laparotomy
12
inflammatory response
12
single preoperative
8
dose intravenous
8
intravenous dexamethasone
8
intestinal obstruction
8

Similar Publications

Purpose: Arthroscopic rotator cuff repair (ARCR) commonly results in significant postoperative pain. Adjuncts like dexamethasone (DEX) and tranexamic acid (TXA) are used to enhance postoperative recovery. This study aimed to determine whether the combined application of TXA and DEX could improve postoperative recovery during the first 24 hours in ARCR patients.

View Article and Find Full Text PDF

Background And Objectives: Post-embolization syndrome (PES), characterized by pain, fever, nausea, and vomiting, is a common but non-serious adverse event following arterial embolization, negatively impacting patient satisfaction with the procedure. This study aimed to evaluate the efficacy of dexamethasone-based prophylactic therapy in preventing PES, as well as to assess the effects of its dosage and timing of administration.

Methods: A systematic search was conducted across three databases, two trial registries, and citation searches to identify relevant studies.

View Article and Find Full Text PDF

Background: Physical activity (PA) and dexamethasone (Dex) when used independently have modest benefits for cancer-related fatigue (CRF) in patients with advanced cancer. In this study we aimed to determine the feasibility (adherence, safety, and satisfaction) of combining PA with Dex versus PA with placebo (PBO) for CRF, and to explore the effects of PA+Dex and PA+PBO on CRF.

Patients And Methods: In this phase II, randomized, double-blind controlled trial, eligible patients had advanced cancer and a CRF score of ≥4 on the Edmonton Symptom Assessment Scale (ESAS) for fatigue (0-10 scale).

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the optimal timing for administering intravenous dexamethasone to prolong pain relief after supraclavicular brachial plexus blockade.
  • Participants were randomly assigned to receive dexamethasone at various times relative to the block, with 158 patients included in the analysis.
  • Results showed no significant differences in pain relief duration, opioid use, or adverse effects among the timing groups, indicating that dexamethasone can be effectively administered at multiple times without impacting pain management outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • Effective pain management post-tonsillectomy in children is crucial, and this study aimed to determine the best analgesics for such procedures.
  • The research involved a systematic review and meta-analysis of 82 studies, examining various analgesic methods and their impact on pain relief and complications in over 6,100 pediatric patients.
  • Key findings showed that local anesthetics, opioids (like morphine), and glucocorticoids (such as dexamethasone) were effective in reducing pain, while dexamethasone also decreased postoperative complications compared to other methods.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!